Literature DB >> 23871696

KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.

Joshua C Black1, Amity L Manning, Capucine Van Rechem, Jaegil Kim, Brendon Ladd, Juok Cho, Cristiana M Pineda, Nancy Murphy, Danette L Daniels, Cristina Montagna, Peter W Lewis, Kimberly Glass, C David Allis, Nicholas J Dyson, Gad Getz, Johnathan R Whetstine.   

Abstract

Acquired chromosomal instability and copy number alterations are hallmarks of cancer. Enzymes capable of promoting site-specific copy number changes have yet to be identified. Here, we demonstrate that H3K9/36me3 lysine demethylase KDM4A/JMJD2A overexpression leads to localized copy gain of 1q12, 1q21, and Xq13.1 without global chromosome instability. KDM4A-amplified tumors have increased copy gains for these same regions. 1q12h copy gain occurs within a single cell cycle, requires S phase, and is not stable but is regenerated each cell division. Sites with increased copy number are rereplicated and have increased KDM4A, MCM, and DNA polymerase occupancy. Suv39h1/KMT1A or HP1γ overexpression suppresses the copy gain, whereas H3K9/K36 methylation interference promotes gain. Our results demonstrate that overexpression of a chromatin modifier results in site-specific copy gains. This begins to establish how copy number changes could originate during tumorigenesis and demonstrates that transient overexpression of specific chromatin modulators could promote these events.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23871696      PMCID: PMC3832053          DOI: 10.1016/j.cell.2013.06.051

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  38 in total

1.  Cell cycle synchronization at the G2/M phase border by reversible inhibition of CDK1.

Authors:  Lyubomir T Vassilev
Journal:  Cell Cycle       Date:  2006-11-15       Impact factor: 4.534

2.  Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype.

Authors:  X R Jiang; G Jimenez; E Chang; M Frolkis; B Kusler; M Sage; M Beeche; A G Bodnar; G M Wahl; T D Tlsty; C P Chiu
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

3.  Gene amplification, drug resistance, and cancer.

Authors:  R T Schimke
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

4.  Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.

Authors:  K Kudoh; M Takano; T Koshikawa; M Hirai; S Yoshida; Y Mano; K Yamamoto; K Ishii; T Kita; Y Kikuchi; I Nagata; M Miwa; K Uchida
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

5.  Rereplication phenomenon in fission yeast requires MCM proteins and other S phase genes.

Authors:  H A Snaith; S L Forsburg
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

6.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22.

Authors:  L M Brzustowicz; K A Hodgkinson; E W Chow; W G Honer; A S Bassett
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

7.  Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.

Authors:  Johnathan R Whetstine; Amanda Nottke; Fei Lan; Maite Huarte; Sarit Smolikov; Zhongzhou Chen; Eric Spooner; En Li; Gongyi Zhang; Monica Colaiacovo; Yang Shi
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

Review 8.  Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer.

Authors:  M Takano; K Kudo; T Goto; K Yamamoto; T Kita; Y Kikuchi
Journal:  Hum Cell       Date:  2001-12       Impact factor: 4.174

9.  Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Authors:  Jun Inoue; Takemi Otsuki; Akira Hirasawa; Issei Imoto; Yoshinobu Matsuo; Shiroh Shimizu; Masafumi Taniwaki; Johji Inazawa
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

10.  Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision.

Authors:  Iain F Davidson; Anatoliy Li; J Julian Blow
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

View more
  111 in total

1.  Too little O2 Too much gain.

Authors:  Joshua C Black; Johnathan R Whetstine
Journal:  Cell Cycle       Date:  2015-07-29       Impact factor: 4.534

Review 2.  An epigenetic gateway to brain tumor cell identity.

Authors:  Stephen C Mack; Christopher G Hubert; Tyler E Miller; Michael D Taylor; Jeremy N Rich
Journal:  Nat Neurosci       Date:  2016-01       Impact factor: 24.884

3.  Histone demethylases and their roles in cancer epigenetics.

Authors:  Alexandra D'Oto; Qing-Wu Tian; Andrew M Davidoff; Jun Yang
Journal:  J Med Oncol Ther       Date:  2016

4.  Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

Authors:  Roselyne M Labbé; Andreana Holowatyj; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

Review 5.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

6.  GPS2/KDM4A pioneering activity regulates promoter-specific recruitment of PPARγ.

Authors:  M Dafne Cardamone; Bogdan Tanasa; Michelle Chan; Carly T Cederquist; Jaclyn Andricovich; Michael G Rosenfeld; Valentina Perissi
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

Review 7.  Epigenetic plasticity and the hallmarks of cancer.

Authors:  William A Flavahan; Elizabeth Gaskell; Bradley E Bernstein
Journal:  Science       Date:  2017-07-21       Impact factor: 47.728

8.  KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis.

Authors:  Ling-Yu Wang; Chiu-Lien Hung; Yun-Ru Chen; Joy C Yang; Junjian Wang; Mel Campbell; Yoshihiro Izumiya; Hong-Wu Chen; Wen-Ching Wang; David K Ann; Hsing-Jien Kung
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

9.  Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity.

Authors:  Hyo Jeong Lee; Bo-Kyoung Kim; Kyoung Bin Yoon; Yong-Chul Kim; Sun-Young Han
Journal:  Invest New Drugs       Date:  2017-09-14       Impact factor: 3.850

10.  Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer.

Authors:  Francesca Bersani; Eunjung Lee; Peter V Kharchenko; Andrew W Xu; Mingzhu Liu; Kristina Xega; Olivia C MacKenzie; Brian W Brannigan; Ben S Wittner; Hyunchul Jung; Sridhar Ramaswamy; Peter J Park; Shyamala Maheswaran; David T Ting; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.